Featured

Monday 10 May to Wednesday 12 May

2021 Clinical Data Disclosure, Transparency and Plain Language Summaries

A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS).
All
Show
  • All
  • News
  • Articles
  • Events

Oxford PharmaGenesis named in Medical Marketing and Media's Agency 100 report

Media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in the latest Agency 100 – the annual definitive ‘who’s who’ ranking of the sector’s top healthcare marketing firms in North America.

Oxford PharmaGenesis and CISCRP strengthen awareness of need for patient diversity

Oxford PharmaGenesis is helping to raise public awareness of the importance of patient diversity in clinical trials through a campaign partnership with the non-profit organization Center for Information and Study on Clinical Research Participation (CISCRP).

Learning at Work Week: Oxford PharmaGenesis boosts colleagues' skills

Oxford PharmaGenesis continues to boost colleagues’ skills and expertise through a wide range of professional and personal development sessions offered to celebrate Learning at Work Week 2021 (17–23 May).

2021 Clinical Data Disclosure, Transparency and Plain Language Summaries

Monday 10 May to Wednesday 12 May A focus of the 2021 Clinical Data Disclosure, Transparency and Plain Language Summaries virtual conference was on the forthcoming implementation of the EU Clinical Trial Regulation (EU CTR) and the launch of the Clinical Trial Information Service (CTIS).  However, the important role of different forms of plain language […]

Kidney disease consensus manuscript published: highlights the need to improve awareness of racial health disparities

Oxford PharmaGenesis is proud to announce the publication of a Delphi consensus manuscript in the Journal of the American Society of Nephrology. The publication highlights the need to increase awareness among key stakeholders of racial health disparities in kidney disease and of APOL1-associated nephropathy.

Oxford PharmaGenesis creates new Director of Innovation role and makes first appointments

Oxford PharmaGenesis has made its first appointments to the new role of Director of Innovation, created specifically to support teams across the global organization in utilizing new and emerging technology to support their clients’ unmet needs.